Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
135 |
|
| Actual shortage: | 33 (24%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (76%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (45%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-LEVOCARB | 25MG 100MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32270 |
| MINT-LEVOCARB | 25MG 250MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32274 |
| MINT-FENOFIBRATE E | 145MG | TABLET | Actual shortage | 2019-04-08 | 2020-04-25 | 80782 |
| MINT-DICLOFENAC | 0.1% | SOLUTION | Actual shortage | 2023-03-27 | 2023-09-27 | 188042 |
| MINT-DICLOFENAC | 0.1% | SOLUTION | Actual shortage | 2023-03-27 | 2023-09-27 | 188045 |
| MINT-OSELTAMIVIR | 75MG | CAPSULE | Actual shortage | 2022-01-05 | 2023-01-03 | 152092 |
| MINT-LETROZOLE | 2.5MG | TABLET | Actual shortage | 2024-01-26 | 2024-01-26 | 217372 |
| MINT-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2024-01-26 | 217384 |
| MINT-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2024-01-26 | 217387 |
| MINT-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2024-01-26 | 217396 |
| MINT-BETAHISTINE | 8MG | TABLET | Actual shortage | 2024-06-10 | 2024-06-10 | 230038 |
| MINT-BETAHISTINE | 16MG | TABLET | Actual shortage | 2024-06-10 | 2024-06-10 | 230041 |
| MINT-BETAHISTINE | 24MG | TABLET | Actual shortage | 2024-06-10 | 2024-06-10 | 230044 |
| MINT-ONDANSETRON | 4MG | TABLET | Resolved | 2017-10-26 | 2018-03-10 | 27164 |
| MINT-ONDANSETRON | 8MG | TABLET | Resolved | 2017-10-26 | 2017-11-22 | 27173 |
| MINT-ONDANSETRON | 8MG | TABLET | Resolved | 2021-01-11 | 2021-03-23 | 131330 |
| MINT-TOPIRAMATE | 25MG | TABLET | Resolved | 2024-01-29 | 2024-03-26 | 217681 |
| MINT-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-11-07 | 2018-01-04 | 28570 |
| MINT-PRAVASTATIN | Resolved | 2017-10-26 | 2018-01-31 | 27153 | ||
| MINT-PRAVASTATIN | 10MG | TABLET TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217375 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
| MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
| MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |